Tradename: VOWST

Proper Name: fecal microbiota spores, live-brpk

Indication: To prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI).           

Approval Date: 04/26/2023

Manufacturer: Seres Therapeutics, Inc.


Leave a Reply

Your email address will not be published. Required fields are marked *